 FORT LEE, N.J., Sept. 07, 2022 GLOBE NEWSWIRE -- Nuvectis Pharma, Inc. Nuvectis, Company, a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced that Ron Bentsur, Chairman and Chief Executive Officer of Nuvectis, will present at the following investor conferences in September. 